1005 GENES FOUND
Show / hide columns
XML |
RDF |
TSV |
« prev | Page next »
IFITM2 Interferon induced transmembrane protein 2 Predicted membrane proteins Expressed in all
IFITM3 Interferon induced transmembrane protein 3 Predicted membrane proteins Expressed in all
IPO11 Importin 11 Plasma proteins Nucleus Expressed in all
IPO13 Importin 13 Predicted intracellular proteins Expressed in all
IPO4 Importin 4 Predicted intracellular proteins Cytosol Tissue enhanced
IPO5 Importin 5 Plasma proteins Nucleoplasm Expressed in all
IPO7 Importin 7 Cancer-related genes Nucleoplasm Expressed in all
IPO8 Importin 8 Predicted intracellular proteins Nucleus Expressed in all
IPO9 Importin 9 Predicted intracellular proteins Vesicles Expressed in all
ITGA1 Integrin, alpha 1 Cancer-related genes Endoplasmic reticulum Mixed
ITGA6 Integrin, alpha 6 Cancer-related genes Expressed in all
ITGB1 Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) Cancer-related genes Endoplasmic reticulum Expressed in all
ITPR1 Inositol 1,4,5-trisphosphate receptor, type 1 Disease related genes Vesicles Tissue enhanced
IZUMO1 Izumo sperm-egg fusion 1 Predicted intracellular proteins Tissue enriched
IZUMO2 IZUMO family member 2 Predicted membrane proteins Tissue enriched
IZUMO4 IZUMO family member 4 Predicted intracellular proteins Nucleoplasm Tissue enriched
KCNA2 Potassium channel, voltage gated shaker related subfamily A, member 2 Disease related genes Tissue enriched
KCNA3 Potassium channel, voltage gated shaker related subfamily A, member 3 FDA approved drug targets Mixed
KCNA5 Potassium channel, voltage gated shaker related subfamily A, member 5 Disease related genes Tissue enhanced
KCNAB1 Potassium channel, voltage gated subfamily A regulatory beta subunit 1 Predicted intracellular proteins Tissue enhanced
KCNB1 Potassium channel, voltage gated Shab related subfamily B, member 1 Disease related genes Tissue enhanced
KCNC3 Potassium channel, voltage gated Shaw related subfamily C, member 3 Disease related genes Tissue enhanced
KCND2 Potassium channel, voltage gated Shal related subfamily D, member 2 Disease related genes Tissue enhanced
KCND3 Potassium channel, voltage gated Shal related subfamily D, member 3 Disease related genes Mixed
KCNF1 Potassium channel, voltage gated modifier subfamily F, member 1 Plasma proteins Golgi apparatus Tissue enriched
KCNH1 Potassium channel, voltage gated eag related subfamily H, member 1 Disease related genes Vesicles Tissue enriched
KCNH3 Potassium channel, voltage gated eag related subfamily H, member 3 Predicted membrane proteins Nucleus Group enriched
KCNIP4 Kv channel interacting protein 4 Predicted intracellular proteins Vesicles Tissue enhanced
KCNJ1 Potassium channel, inwardly rectifying subfamily J, member 1 Disease related genes Tissue enriched
KCNJ16 Potassium channel, inwardly rectifying subfamily J, member 16 Predicted intracellular proteins Vesicles Group enriched
KCNJ2 Potassium channel, inwardly rectifying subfamily J, member 2 Disease related genes Tissue enhanced
KCNJ3 Potassium channel, inwardly rectifying subfamily J, member 3 Plasma proteins Tissue enhanced
KCNJ5 Potassium channel, inwardly rectifying subfamily J, member 5 Cancer-related genes Tissue enhanced
KCNJ8 Potassium channel, inwardly rectifying subfamily J, member 8 Disease related genes Mixed
KCNK15 Potassium channel, two pore domain subfamily K, member 15 Predicted membrane proteins Tissue enhanced
KCNK17 Potassium channel, two pore domain subfamily K, member 17 Predicted membrane proteins Tissue enhanced
KCNK5 Potassium channel, two pore domain subfamily K, member 5 Predicted membrane proteins Nucleus Tissue enhanced
KCNK6 Potassium channel, two pore domain subfamily K, member 6 Predicted membrane proteins Plasma membrane Mixed
KCNMB2 Potassium channel subfamily M regulatory beta subunit 2 Predicted membrane proteins Tissue enhanced
KCNMB3 Potassium channel subfamily M regulatory beta subunit 3 Predicted intracellular proteins Nucleus Mixed
KCNN2 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 2 Plasma proteins Nucleoplasm Tissue enhanced
KCNN4 Potassium channel, calcium activated intermediate/small conductance subfamily N alpha, member 4 Disease related genes Tissue enhanced
KCNQ1 Potassium channel, voltage gated KQT-like subfamily Q, member 1 Disease related genes Tissue enhanced
KCNQ2 Potassium channel, voltage gated KQT-like subfamily Q, member 2 Disease related genes Endoplasmic reticulum Tissue enriched
KCNQ4 Potassium channel, voltage gated KQT-like subfamily Q, member 4 Disease related genes Mixed
KCNS2 Potassium voltage-gated channel, modifier subfamily S, member 2 Predicted membrane proteins Tissue enhanced
KCNS3 Potassium voltage-gated channel, modifier subfamily S, member 3 Predicted intracellular proteins Golgi apparatus Tissue enhanced
KCNT1 Potassium channel, sodium activated subfamily T, member 1 Disease related genes Group enriched
KCNT2 Potassium channel, sodium activated subfamily T, member 2 Predicted intracellular proteins Vesicles Tissue enhanced
KDELR1 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 1 Predicted membrane proteins Golgi apparatus Expressed in all
« prev | Page next »
